(Q37800307)

23 August 2017

title

Stem cell transplantation: progress in Asia (English)

1 reference

stem cell transplantation

23 August 2017

main subject

1 reference

L Sun

1

1 reference

23 August 2017

publication date

1 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

19

1 reference

23 August 2017

issue

12

1 reference

23 August 2017

page(s)

1468-1473

1 reference

ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Lupus in Hong Kong Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Demographic differences in the development of lupus nephritis: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Lupus in the developing world--is it any different?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Systemic lupus erythematosus in Saudi Arabia: morbidity and mortality in a multiethnic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Clinical and immunological manifestations in 624 SLE patients in Saudi Arabia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Advances in the treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Immunopathology and the gene therapy of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Stem cell transplantation for autoimmune disease: progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Multilineage cells from human adipose tissue: implications for cell-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Stem cells in the umbilical cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

B-cell-directed therapies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Interactions between human mesenchymal stem cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310370051

21 January 2018

Identifiers

DOI

10.1177/0961203310370051

1 reference

23 August 2017

1 reference